Cytek Biosciences, Inc.
NASDAQ:CTKB
6.83 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 51.5 | 46.617 | 44.86 | 58.233 | 48 | 49.693 | 37.088 | 48.336 | 40.477 | 40.159 | 35.064 | 38.894 | 34.376 | 30.408 | 24.272 | 30.619 | 25.096 | 19.136 | 17.988 |
| Cost of Revenue
| 22.495 | 21.181 | 21.847 | 25.185 | 20.822 | 21.531 | 16.05 | 18.962 | 13.615 | 15.598 | 14.887 | 15.258 | 12.99 | 10.663 | 9.786 | 11.17 | 9.48 | 10.866 | 9.613 |
| Gross Profit
| 29.005 | 25.436 | 23.013 | 33.048 | 27.178 | 28.162 | 21.038 | 29.374 | 26.862 | 24.561 | 20.177 | 23.636 | 21.386 | 19.745 | 14.486 | 19.449 | 15.616 | 8.27 | 8.375 |
| Gross Profit Ratio
| 0.563 | 0.546 | 0.513 | 0.568 | 0.566 | 0.567 | 0.567 | 0.608 | 0.664 | 0.612 | 0.575 | 0.608 | 0.622 | 0.649 | 0.597 | 0.635 | 0.622 | 0.432 | 0.466 |
| Reseach & Development Expenses
| 9.882 | 10.001 | 9.796 | 10.869 | 11.171 | 12.136 | 9.974 | 9.747 | 8.65 | 8.436 | 8.025 | 7.076 | 6.078 | 6.194 | 5.094 | 4.385 | 3.376 | 2.916 | 3.016 |
| General & Administrative Expenses
| 10.942 | 11.694 | 11.408 | 10.755 | 10.351 | 10.786 | 12.081 | 10.514 | 8.042 | 8.585 | 7.549 | 6.929 | 5.905 | 4.164 | 3.983 | 2.628 | 1.691 | 2.513 | 2.538 |
| Selling & Marketing Expenses
| 12.429 | 12.268 | 12.543 | 11.561 | 12.076 | 14.367 | 11.145 | 9.029 | 8.81 | 8.431 | 6.96 | 8.304 | 6.331 | 5.576 | 4.277 | 4.56 | 3.838 | 3.059 | 3.531 |
| SG&A
| 23.371 | 23.962 | 23.951 | 22.316 | 22.427 | 25.153 | 23.226 | 19.543 | 16.852 | 17.016 | 14.509 | 15.233 | 12.236 | 9.74 | 8.26 | 7.188 | 5.529 | 5.572 | 6.069 |
| Other Expenses
| 0 | 0.059 | 0.823 | 3.194 | 1.208 | 1.74 | 1.652 | 0 | -0.445 | -0.254 | -0.374 | -0.399 | -0.393 | -0.12 | -0.615 | 0.451 | 0.185 | 0.395 | -0.037 |
| Operating Expenses
| 33.253 | 33.963 | 33.747 | 33.185 | 33.598 | 37.289 | 33.2 | 29.29 | 25.502 | 25.452 | 22.534 | 22.309 | 18.314 | 15.934 | 13.354 | 11.573 | 8.905 | 8.488 | 9.085 |
| Operating Income
| -4.248 | -8.527 | -10.734 | -0.137 | -6.42 | -9.127 | -12.162 | 0.084 | 2.499 | -0.891 | -2.357 | 1.327 | 3.072 | 3.811 | 1.132 | 7.876 | 6.711 | -0.218 | -0.71 |
| Operating Income Ratio
| -0.082 | -0.183 | -0.239 | -0.002 | -0.134 | -0.184 | -0.328 | 0.002 | 0.062 | -0.022 | -0.067 | 0.034 | 0.089 | 0.125 | 0.047 | 0.257 | 0.267 | -0.011 | -0.039 |
| Total Other Income Expenses Net
| 4.405 | 1.341 | 1.741 | 4.248 | 2.235 | 2.532 | 3.122 | 4.03 | 0.49 | -0.51 | -0.946 | -0.873 | -0.822 | -0.544 | -0.98 | 0.126 | 0.186 | 0.41 | 0.049 |
| Income Before Tax
| 0.157 | -7.186 | -8.993 | 4.111 | -4.185 | -6.595 | -9.04 | 4.114 | 1.85 | -1.401 | -3.303 | 0.454 | 2.25 | 3.267 | 0.152 | 8.002 | 6.897 | 0.192 | -0.661 |
| Income Before Tax Ratio
| 0.003 | -0.154 | -0.2 | 0.071 | -0.087 | -0.133 | -0.244 | 0.085 | 0.046 | -0.035 | -0.094 | 0.012 | 0.065 | 0.107 | 0.006 | 0.261 | 0.275 | 0.01 | -0.037 |
| Income Tax Expense
| -0.784 | 3.248 | -2.824 | -1.392 | 2.271 | -2.207 | -2.233 | 0.396 | 0.224 | -0.699 | -1.145 | 0.203 | 0.655 | 0.597 | 0.05 | 2.403 | 0.357 | -7.919 | 0.178 |
| Net Income
| 0.941 | -10.434 | -6.169 | 5.503 | -6.456 | -4.388 | -6.807 | 3.529 | 1.666 | -0.598 | -2.158 | 0.225 | 1.595 | 2.67 | 0.102 | 5.599 | 6.54 | 8.111 | -0.839 |
| Net Income Ratio
| 0.018 | -0.224 | -0.138 | 0.094 | -0.135 | -0.088 | -0.184 | 0.073 | 0.041 | -0.015 | -0.062 | 0.006 | 0.046 | 0.088 | 0.004 | 0.183 | 0.261 | 0.424 | -0.047 |
| EPS
| 0.007 | -0.079 | -0.047 | 0.042 | -0.047 | -0.032 | -0.05 | 0 | 0.012 | -0.004 | -0.016 | 0.002 | 0.015 | 0.02 | 0.001 | 0.047 | 0.21 | 0.26 | -0.007 |
| EPS Diluted
| 0.007 | -0.079 | -0.047 | 0.042 | -0.047 | -0.032 | -0.05 | 0 | 0.012 | -0.004 | -0.016 | 0.002 | 0.014 | 0.02 | 0.001 | 0.046 | 0.18 | 0.23 | -0.007 |
| EBITDA
| 3.083 | -4.572 | -6.092 | 2.288 | -1.031 | -4.566 | -7.366 | 6.665 | 3.83 | 0.112 | -1.919 | 2.232 | 2.71 | 3.9 | 0.694 | 8.034 | 7.078 | 0.354 | -0.556 |
| EBITDA Ratio
| 0.06 | -0.13 | -0.184 | 0.039 | -0.075 | -0.075 | -0.226 | 0.138 | 0.081 | 0.02 | -0.035 | 0.024 | 0.078 | 0.122 | 0.029 | 0.277 | 0.282 | 0.018 | -0.031 |